MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Integrating the Collaborative Care Mental Health Model into Virtual Parkinson’s Disease Care

    E. Ferluga, E. Anderson, N. Flanagan, D. Geraldi-Samara, J. Riser, K. Brendle (Chicago, USA)

    Objective: In Parkinson’s Disease (PD), neuropsychiatric symptoms start in the prodromal stage.  Increased rates of depression and anxiety in PD have been associated with living…
  • 2025 International Congress

    Biological Characteristics of Individuals with RBD: A Multicenter Prospective Longitudinal Cohort

    J. Feuerstein, E. Brown, L. Chahine, C. Gochanour, D. Lafontant, M. Marshall, T. Simuni, D. Weintraub (Aurora, USA)

    Objective: Examine baseline clinical and biological characteristics of participants with polysomnography-confirmed REM Sleep Behavior Disorder (RBD). Background: RBD is an early manifestation of underlying synucleinopathy…
  • 2025 International Congress

    Life Course Sleep Duration Trajectories and Risk and Age at Onset of Parkinson’s Disease

    Y. Fang, R. Hardy, K. Yaffe, S. Little, C. Tanner, Y. Leng (San Francisco, USA)

    Objective: To characterize life course sleep duration trajectories and examine their associations with PD risk and age at onset (AAO). Background: Sleep disturbances could be…
  • 2025 International Congress

    Comparison of clinical symptoms between young-onset and elderly-onset in patient with early Parkinson’s disease

    M. Iijima, R. Morimoto, K. Suzuki, S. Nogawa, Y. Okuma (Tokyo, Japan)

    Objective: We compared the clinical symptoms of early Parkinson's disease (PD) between young-onset and elderly-onset. Background: The progression of PD varies depending on the age…
  • 2025 International Congress

    Quality of Life Impact on Adults with Parkinson’s Disease Experiencing Morning Akinesia: Real-World Observational Findings

    O. de Fabregues, K. Onuk, C. Yan, P. Kukreja, L. Bergmann, S. Colman, D. Falconer, J. Sarna, F. Ory-Magne, L. Defebvre, V. Fung (Barcelona, Spain)

    Objective: To compare the quality of life (QoL) in Parkinson’s Disease (PD) patients with and without morning akinesia (MA) in those using oral medications only…
  • 2025 International Congress

    Movement-Disorders Focused Clinical Neuroscience Training for Psychiatry Residents: A Competency-Based Medical Education Model

    A. Seritan (San Francisco, USA)

    Objective: To illustrate a novel educational program model that can train psychiatrists to develop competencies in caring for patients with movement disorders such as Parkinson's…
  • 2025 International Congress

    Lung Function and the Risk of Parkinson’s Disease: A Population-based Cohort Study

    JY. Liu, SC. Wang, XT. Zheng, SR. Zhang, QR. Jiang, CY. Li, HF. Shang (Chengdu, Sichuan, China)

    Objective: The study aims to explore the association between lung function and the risk to develop PD. Background: Some researchers have noted a faster decline…
  • 2025 International Congress

    Digital Health Interventions for Parkinson’s Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

    RW. Liu, SR. Zhang, YF. Chen, HF. Shang (Chengdu, China)

    Objective: To assess the effectiveness of digital health interventions (DHIs) in patients with Parkinson's disease (PD) and report on their reach, uptake, and feasibility. Background:…
  • 2025 International Congress

    Oxidative stress in Progressive Supranuclear Palsy

    P. Alster, D. Otto-ślusarczyk, M. Struga, N. Madetko-Alster (Warsaw, Poland)

    Objective: The goal of the study is to evaluate the significance of oxidative stress in the examination and pathophysiology of Progressive Supranuclear Palsy (PSP). Additionally,…
  • 2025 International Congress

    Developing a novel Disease-Specific iPSC Model for Studying MSA Pathogenesis

    A. Perez-Soriano, M. Alemany-Ribes, B. Crespo, F. Kohler, B. Fuste, M. Perez-Soriano, D. Cohen, R. Fernandez-Santiago, M. Ezquerra, MJ. Martí, V. Baekelandt, W. Peelaerts, R. Melki, L. Batlle-Morera, . (Barcelona, Spain)

    Objective: This study aims to develop a human iPSC-derived oligodendrocyte (iPSC-OL) model to investigate cell-specific disease mechanisms in MSA. Specifically, we seek to:a)Generate MSA patient-derived…
  • « Previous Page
  • 1
  • …
  • 383
  • 384
  • 385
  • 386
  • 387
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley